Press release
Adipose-derived Stem Cell Market Growth and Restrain Factors Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the ""Global Adipose-derived Stem Cell Market (Cell type (Autologous and Allogeneic stem cells), Product Type (Cell Line, Culture Media, Media, Sera And Reagents), Disease Conditions (Cancer, Obesity, Wounds And Injuries, Cardiovascular Diseases, Musculoskeletol Diseases And Others), Application (Therapeutic, Research, Others ), End-User (Cell Banks & Tissue Banks, Research Laboratories And Academic institutes, Hospitals and Trauma centers and Other end user industries)) -Trends, Industry Competition Analysis, Revenue and Forecast To 2031".The Adipose-derived Stem Cell Market Size is valued at 1129.84 Million in 2022 and is predicted to reach 3519.06 Million by the year 2031 at a 13.92 % CAGR during the forecast period for 2023-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1360
The extraction of adult stem cells suitable for tissue engineering and regenerative medicine applications can now be accomplished using adipose tissue, which is a convenient, abundant, and stable source. Preclinical research on the isolation, characterization, cryopreservation, differentiation, and transplantation of newly isolated stromal vascular fraction cells and adherent, culture-expanded, adipose-derived stromal/stem cells in vitro and animal models has exploded in the past ten years.
The richness of the ADSC plays a crucial role in the restorative abilities of fat grafting.
It is necessary to follow an isolation protocol for separating ADSCs from adipose tissue, and quality, safety, and effectiveness should all be considered. According to research, ADSCs can boost revascularization, activate regional stem cell niches, lessen oxidative stress, and control immunological reactions. ADSC products are attractive regenerative cell therapies because they can be retrieved in significant quantities with minor damage to the donor site.
As ADSCs become more valuable in clinical settings, the goal of making ADSCs that are good enough for clinical use becomes more critical. Several countries have noticed that the industry of cell therapies is growing and have put in place rules to make sure they are safe.
There are a number of key market drivers for the adipose-derived stem cell market, including increasing regulatory approvals for clinical trials of ADSCs medicines and increasing funding for the development of regenerative therapies. In addition, there has been a recent rise in the formation of strategic collaborations between research institutes and manufacturers to accelerate the process of discovering new drugs and isolating them.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1360
It is possible that disease-causing bacteria, viruses, or other pathogens will be introduced into the processing phase of adipose-derived stem cell therapy, which can lead to an infection. This is a potential consequence of adipose-derived stem cell therapy. Additionally, there are some constraints regarding the preservation and delivery of the cells, both of which will be responsible for restraining the market's growth.
The North American region will dominate the ADSC market. Consistently rising investments in research and development over the past decade bode well for rapid and widespread progress in this therapeutic field.
Major market players are Allocure, Inc., Celgene Corporation, Pluristem Therapeutics, Inc. (Pluri, Inc), Intrexon, Inc., Celleris SA, Tissue Genesis, Inc., Mesoblast Ltd., Cytori Therapeutics, Antria, Inc., ThermoFisher Scientific, American CrysoStem, Merck KGaA, and Other Prominent players.
Key Developments in the market
• In July 2022, The name change from Pluristem Therapeutics, Inc. to Pluri, Inc. reflects the company's goal of expanding the use of its cutting-edge 3D cell-based technology platform beyond the healthcare sector. Pluri's advanced technology will sustain the advancement of healthcare and pharmaceuticals.
• In Dec 2021, Pluristem and the pharmaceutical company, Innovare R&D teamed up to bring the ARDS programme linked to COVID-19 to Mexico. Innovare will initiate clinical sites and patient enrollment for the proposed clinical study in Mexico under the terms of the agreement. Innovare will provide the funding for the Mexican study and will acquire the PLX cells for the study from Pluristem.
• In Nov 2019, It was announced by Celgene that after the acquisition by Bristol Myers Squibb is finalized, Celgene intends to transfer the listing of its contingent value rights. After the deal was finalized, Celgene became a wholly owned subsidiary of Bristol-Myers Squibb Company, as stated in the merger agreement.
• In Aug 2019, The U.S. FDA approved INREBIC® (Fedratinib) as the first novel therapy for myelofibrosis patients in almost a decade. INREBIC offers patients a novel, once-daily oral treatment alternative for their uncommon bone marrow cancer.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1360
Market Segmentation:
Global Adipose-derived Stem Cell Market, by Cell Type, 2022-2030 (Value US$ Mn)
• Autologous stem cells
• Allogeneic stem cells
Global Adipose-derived Stem Cell Market, by Product Type, 2022-2030 (Value US$ Mn)
• Cell line
• Culture Media
• Media
• Sera
• Reagents
Global Adipose-derived Stem Cell Market, by Disease Indication, 2022-2030 (Value US$ Mn)
• Cancer
• Obesity
• Wounds and Injuries
• Cardiovascular diseases
• Musculoskeletal diseases
• Others
Global Adipose-derived Stem Cell Market, by Application, 2022-2030 (Value US$ Mn)
• Therapeutic
• Research
• Others
Global Adipose-derived Stem Cell Market, by End-user Industry, 2022-2030 (Value US$ Mn)
• Cell banks & Tissue banks
• Research laboratories and Academic institutes
• Hospitals and Trauma centers
• Others
Global Adipose-derived Stem Cell Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Adipose-derived Stem Cell Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
> To receive a comprehensive analysis of the prospects for the global Adipose-derived Stem Cell Market
> To receive an industry overview and future trends of the Adipose-derived Stem Cell Market
> To analyze the Adipose-derived Stem Cell Market drivers and challenges
> To get information on the Adipose-derived Stem Cell Market size (Value US$ Mn) forecast to 2030
> Significant investments, mergers & acquisitions in the Adipose-derived Stem Cell Market industry
For More Information : https://www.insightaceanalytic.com/report/global-adipose-derived-stem-cell-market/1360
Other Related Reports Published by InsightAce Analytic:
Global Allogeneic Cell Therapy Manufacturing Market
Global Regulatory T-Cell (Tregs) Therapies Market
Global Stem Cell Exosome Therapeutic Market
Global Allogenic Cell Therapies Market
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adipose-derived Stem Cell Market Growth and Restrain Factors Analysis Report here
News-ID: 3335007 • Views: …
More Releases from Insightace analytic

Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…

Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…

Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…

Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Cell
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…